UPDATE: UBS Cuts PT to $64.50 on Bed Bath & Beyond on Q3 Pressure

By: Benzinga
UBS reiterated its Neutral rating on Bed Bath & Beyond (NASDAQ: BBBY ) and reduced its price target from $71 to $64.50. UBS commented, "Our EPS est. of $1.03 is slightly ahead of the cons. $1.02, but the components of the results will matter just as much as the
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.